Sprinkler cannula

Information

  • Patent Grant
  • 11020526
  • Patent Number
    11,020,526
  • Date Filed
    Friday, September 30, 2011
    13 years ago
  • Date Issued
    Tuesday, June 1, 2021
    3 years ago
Abstract
An infusion device (50) incl. a preferably soft cannula (1) configured to be inserted by means of an insertion needle. The cannula has a tubular body member having a proximal end and a subcutaneously placed distal portion having a distal end where the distal portion is provided with an opening (2) allowing a portion of a drug conveyed through the tubular body member to discharge. The cannula further comprise, in the distal portion, a radial opening allowing a portion of a drug conveyed through the tubular body member to discharge.
Description

The present invention relates to an infusion device configured for introduction of a fluid drug into the human body. Specifically, the present invention relates to an infusion including a cannula configured for this purpose.


According to one aspect, the present invention relates to an infusion device including a cannula having a tubular body member with a proximal end and a subcutaneously placed distal portion having a distal end. The distal portion is provided with a radial opening allowing a portion of a drug conveyed through the tubular body member to discharge.


In general terms, an infusion device inter alia comprises following sub components:

    • a hub like part comprising a body of hard material fastened to a patients skin via a mounting pad,
    • a pump, and
    • a cannula.


The proximal portion of a cannula is in this specification defined as a portion placed above the skin surface of the patient during use, and the distal portion of a cannula is in this specification defined as the portion which, after mounting, is placed subcutaneously i.e. below the skin surface of the patient. The distal end opening will normally be open allowing fluid to discharge, however according to certain applications and embodiments, the opening may be closed thereby increasing the fluid pressure on the radial opening or openings.


BACKGROUND

Hypodermic cannulas or needles have been used to introduce fluid drugs to the body of human beings as well as animals for over a century.


The use of these cannulas for this purpose has long been the method of last resort, especially for the injection of medications because of the pain associated with the forcing of the needle into the body. Over the years, manufacturers of these cannulas learned that the smaller the diameter of the cannula, and the sharper the point of the introducing needle, the more comfortable the injection would be, and as a consequence, it is today common practise to inject drugs by means of very fine cannulas.


There is, however, a limit to the degree to which the diameter of these cannulas may be reduced. One limitation is established by the flow rate of fluid drug along the cannula which is related to the fourth power of the diameter of the conduit. As the diameter is reduced, the flow rate, at similar pressure, rapidly decreases. If a certain volume of fluid is to be injected and the diameter of the conduit to be reduced, either the pressure used to move the fluid along within the cannula, or the time allotted for introducing the fluid, will increase.


Fluids such as insulin for treatment of diabetes are usually injected in the home by the patent. Such individuals may be unable to exert sufficient pressure to inject their insulin in a satisfactorily short period of time if the diameter of the cannula is too small.


One way to increase the flow rate of a fluid passing through a cannula is to place openings along the side of the needle. Such needles, known as sprinkler needles, are known in the art and are described, for example, by Gross in U.S. Pat. No. 6,261,272. The additional openings on the side of the needle provide additional access to the tissue creating a shorter fluid path to the tissue and also increasing the area of access to the tissue whereby the effective area of the outlet of the needle is increased. These advantages exist both in the delivery of the fluid to the tissue and in the extraction of fluid from the tissue.


A direct result of the sprinkler needle being able to deliver the fluid to a larger volume or area of tissue is a reduction of the pressure required to deliver the fluid. Further, and equally important, increasing the surface area of tissue exposed to the fluid enhances the absorption rate of the fluid by the body.


GB 2459101 A discloses a subcutaneous port and fenestrated catheter for the administration of fluids subcutaneously to be infused over a large volume of tissue. The port contains a subcutaneous chamber covered by a septum through which fluid is received from a hypodermic needle. The chamber has an exit hole with a nipple which connects to a catheter which has perforations. The port and catheter is implanted under the skin of the patient. According to the document, the port may have more than one exit hole connected to other catheters. GB 2459101 A is considered to represent relevant prior art with respect to the present invention because the reference is directed to frequent subcutanous infusion of a medicament by means of a cannula or catheter comprising one or more radial openings such that the fluid administered are received by a large tissue area.


US 2007/0129691 A disclose a laminated sprinkler needle for introduction and extraction of liquids from an animal. The needle comprising a substrate, a micro machined photo resistive layer and a micro porous layer. The structure is of simple construction and fabrication and, according to the document, provides higher flow rates than standard hollow cannulas.


While sprinkler needles have a performance advantage over straight cannula needles, this performance advantage comes at a significantly higher manufacturing cost. The additional openings must be cut in the sides of the needle which requires more time for manufacturing as well as additional manufacturing setups, and further, the openings must further be deburred in order to make sure the pain of insertion is low.


US 2005/0107743 A disclose an infusion set comprising a base member, an introducer cap and an infusion cap. The base member comprises a soft cannula extending from a lower side of the base member and a port on an upper side thereof. The port is configured to be in fluid communication with the soft cannula. The port also comprises a septum adapted to seal the port against unwanted fluid flow. The introducer cap is adapted to be mounted to the base member and has a needle adapted to extend through the septum and said soft cannula in an assembled position. The infusion cap comprises a lumen adapted to receive a flexible tube. The infusion cap also comprises a hard cannula adapted to be inserted through the septum and to place said soft cannula in fluid communication with said lumen. The soft cannula according to US 2005/0107743 A give rise to two problems, one being that the soft cannula is disposed for kinking and the another is that the soft cannula according to US 2005/0107743 A suffers from similar delivery restrictions as already mentioned above.


WO 2002/083228 A2 discloses a fairly advanced syringe or catheter system capable of injecting, manually or automatically; precisely measured quantities of liquids into a body. A plurality of needle designs is disclosed and according to the reference, the designs create advantageously shaped or diffused clouds, streams, or jets of medicament and the like. Generally, the reference seeks to set forth a syringe or catheter allowing for controlled injection of a medicament without substantial damage to tissue. According to the reference, the teachings of the reference may be applied to a relatively long and soft catheter or a rigid needle.


WO 2004/024219 A1 discloses a method and apparatus for epidermal or intradermal delivery of a medicament. A needle having at least one side port is used to penetrate the skin of a subject. The medicament is delivered through the side port and into the skin.


US 2010/0022956 A, by the applicant of the present invention, discloses an infusion set improvable by the teachings of the present application.


An infusion device comprising a cannula to be inserted by means of an insertion needle having following characteristics is much desired:

    • The cannula which is cheap and simple to manufacture,
    • The cannula which is user friendly and cause as little pain as possible to the end user, and
    • The cannula which is configured such that it will mitigate the effects of kinking.


BRIEF DESCRIPTION OF THE INVENTION

The present invention seeks generally to improve today's infusion devices such that the abovementioned insufficiencies and drawbacks of today's infusion devices are overcome.


Up to this day, prior art has failed to teach a simple and yet reliable and inexpensive infusion device which in a safe and reliable manner, without substantially increasing the cost of the device, is able to satisfy the abovementioned much desired characteristics of the mentioned infusion device.


According to the invention, there is provided an infusion device as per the introductory part of this specification, and in particular, upon configuring the infusion device such that the infusion device further comprise a hub part configured to be fastened onto an outside surface of a patients skin via a mounting pad, an infusion device resolving the abovementioned drawbacks are provided.


According to one embodiment, the infusion device may further include a pump configured to be in fluid connection with a reservoir configured to store or hold medication.


According to one embodiment, the subcutaneously placed distal portion may be made from soft material.


According to one embodiment, the cannula may be configured to be inserted by means of an insertion needle.


According to one embodiment the radial opening or openings may, when the cannula is inserted, be provided at least 1 millimeter below the skin surface.


According to one embodiment, the radial opening or openings may, when the cannula is inserted, be provided no more than 9 millimeter below the skin surface.


According to one embodiment, the radial opening may, when the cannula is inserted, be provided below the basal membrane.


According to one embodiment, the radial opening or openings may, when the cannula is inserted, be provided no more than 3 millimeter below the skin surface.


According to one embodiment, the cannula may further comprise a plurality of radial openings allowing a portion of a drug conveyed through the tubular body member to discharge.


According to one embodiment, the radial openings may be apportioned such that the radial openings extend only through one wall of the tubular body member. Further, the radial openings may or may not extend axially along a straight line along the tubular body member.


According to one embodiment, one or more radial openings may extend through the tubular body member in an angle lying approximately perpendicular to a longitudinal axis of the cannula.


According to one embodiment, one or more radial openings may extend through the tubular body member in at least one angle oriented different from an angle lying perpendicular to a longitudinal axis of the cannula.


According to one embodiment, the radial openings that may extend through the tubular body member may have substantially equal diameter.


According to one embodiment, the radial openings that may extend through the tubular body member may have varying diameter.


According to one embodiment, the radial openings which may have varying diameter may be arranged such that the opening having the largest diameter is arranged nearest the distal portion of the cannula.


According to one embodiment, the radial openings, which may have varying diameter, further may be arranged such that the radial opening having the smallest diameter is arranged nearest the proximal end of the cannula.


According to one embodiment, the length of the distal portion of the cannula may be less than 15 mm and the outer diameter of the distal portion may be less than 1.5 mm and the diameter of the one or more radial openings may be between 15 μm and 0.3 mm.


According to one embodiment, the infusion device may be configured for subcutaneous infusion of drugs such as insulin and the like.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a plane view of an embodiment of a cannula applicable to the infusion device according to the present invention.



FIG. 2 is an infusion device according to the present invention.



FIG. 3 is a plane view of a cannula applicable to the infusion device according to the present invention, here shown together with a part of an insertion needle.



FIG. 4 is a plane view of an embodiment of a cannula applicable to the infusion device according to the present invention.



FIG. 5 is a plane view of an embodiment of a cannula applicable to the infusion device according to the present invention.



FIG. 6 is an end view of an embodiment of a cannula applicable to the infusion device according to the present invention.





DETAILED DESCRIPTION OF THE INVENTION WITH REFERENCE TO THE FIGURES


FIG. 1 shows a plane view of one embodiment of a cannula 1 applicable to an infusion device according to the present invention.


The remaining parts and components of the infusion device is considered well known to those skilled in the relevant art, and therefore, such parts and components will only be briefly described in this specification, see FIG. 2.


As can be seen in FIG. 1 the cannula 1 is provided with a tubular body member 3 having a conduit shown by the dashed lines. The conduit interconnects the in this figure not shown infusion device with the openings 2 and 5. The cannula 1 includes a proximal end 10 configured for interconnection with the not shown infusion device as well as a distal portion 21 configured for subcutaneously placement by means of the insertion needle 70 shown in FIG. 3.


Numeral 5 refers to an outlet arranged in the distal portion 21, opposite the interconnection with the infusion device. The outlet 5 may or may not be considered the primary outlet for drugs 4. In addition to the outlet 5, the cannula 1 is provided with at least one further opening 2.


Although FIGS. 1-4 disclose the cannula 1 including a plurality of openings 2, the present invention is not in any way limited to embodiments of the cannula 1 comprising more than one opening 2, see FIG. 5.


The subcutaneously placed distal portion 21, alternatively the entire cannula 1, may be made from a soft material such as PTFE (Teflon), FEP, rubber, PE material or silicone base materials and the like.


At least one of the radial openings 2 may, when the cannula 1 is inserted, be provided at between 1 and 9 millimeter below the skin surface 55, see FIG. 2.



FIG. 2 illustrates schematically an infusion device according to the present invention. The infusion device 50 includes a cannula 1 having a tubular body member 3 with a proximal end 10 and a subcutaneously placed distal portion 21 having a distal end 20. The distal portion 21 of the cannula may be provided with a radial opening 2 allowing a portion of a drug 4 conveyed through the tubular body member 3 to discharge.


The infusion device according to FIG. 2 further include a hub part 51 configured to be fastened onto an outside surface of a patients skin 55 via a mounting pad 52. The mounting pad 52 may be provided with an adhesive layer, configured to adhere to a patient's skin, and a not shown removable release liner which covers the adhesive layer. The mounting pad 52 may be a dressing, a plaster, an adhesive pad or the like and the mounting pad may be configured in various shapes such as oval, circular, triangular rectangular etc.


According to one embodiment, the infusion device may include a hub part 51 having a main plane being essentially parallel to the skin of the patient, when the infusion set is attached to a patient. The hub part 51 may have a main 54 surface being closest to the skin of a patient, and the main surface may be provided with fastening means such as the mounting pad 52 for fastening the infusion device to the skin 55 of a patient.


In the embodiment according to FIG. 2, the cannula 1 extends from the hub part 51 through the fastening means or mounting pad 52. Alternatively the cannula 1 may extend from the hub part 51 of the infusion device essentially along an inclined axis of insertion (not shown).


As shown in FIG. 2, the hub part 51 may include a septum or barrier 53.


As can be seen in FIGS. 1-4, the cannula 1 may be provided with a plurality of radial openings 2 allowing the drug 4, conveyed through the tubular body member or hollow 3, to discharge. The openings 2 may be apportioned such that the openings 2 extend through one wall of the tubular body member 3 only, see FIG. 4. Further, the radial openings 2 may extend axially along a not shown straight line along the cannula 1. The radial openings 2 may, in other embodiments, be placed on different quarters of the cannula 1 such that all the holes are not blocked when pressure is applied to one side of the cannula 1.


The opening or openings 2 may or may not extend through said tubular body member in an angle lying approximately perpendicular to a longitudinal axis of the cannula 1. Further, the opening or openings 2 may extend through the tubular body member in at least one angle oriented different from an angle lying perpendicular to the longitudinal axis 100 of the cannula 1, as shown in FIG. 4.


The angles may constitute any angle between 0° and 180° relative to the longitudinal axis 100; however angles lying in-between 30° and 150°, alternatively 60° and 120° or even 90° may be preferred.


The radial opening or openings 2 may have substantially equal diameter, although this is not in any way a requirement of the present invention. The opening or openings 2 may, according to certain embodiments, also have varying diameter.


It may be preferred to apply the radial opening or openings 2 as a spherical opening or openings; however other forms of opening or openings may equally be applied as long as the opening or openings do not adversely affect the strength and functionality of the cannula 1.


In case the cannula is provided with radial openings 2 having varying diameter, the openings 2 may be arranged such that the opening 2 having the largest diameter is arranged nearest the distal portion 21 of the cannula 1, whereby a substantially uniform outlet of fluid may be obtained over the length of the cannulas distal portion 21.


The length 30 of the distal portion 21 of the cannula 1 may be less than 30 mm, preferably 15 mm, and the outer diameter 35 of the distal portion 20 may be less that 2 mm, preferably less than 1.5 mm and the diameter of the opening or openings 2 may be between 10 μm and 0.5 mm, preferably between 25 μm and 0.3 mm.


The distal end 20 of the cannula 1 may or may not be tapered such as shown in FIG. 4. Providing the distal end 20 of the cannula 1 with a tapered end may facilitate insertion of the cannula 1. Although only the embodiment according to FIG. 4 is shown with a slant and tapered end, this may not in any way be considered limiting to other embodiments according to this specification.


The number of radial openings may, as already mentioned, vary from only one, such as shown in FIG. 5, to any number of openings, however according to one preferred embodiment, the cannula is provided with two radial openings, such as shown in the end view according to FIG. 6.


According to a well functioning embodiment, the cannula may be provided with two radial openings, or sprinkler holes, which are not located opposite each other, i.e. the openings are offset longitudinally as well as with respect to an angle seen from the end or circular cross section. A well functioning angle between the opening are considered to be 120 degree, see FIG. 6.


The opening or openings may be provided, by means of drilling, punching, cutting or equivalent, in any angle to the longitudinal axis 100 of the cannula 1.


Generally seen, the cannula for the infusion device according to the present invention allows a drug such as insulin to be absorbed faster in the blood of the patient than the “one-outlet” soft cannulas according to today's infusion devices comprising cannulas made from a soft material.


According to certain aspects of the present invention, it has been found that one or more radial openings reduce soft cannulas well known tendency to occlude, e.g. due to kinking. Hence the cannula for the infusion device according to the present invention is less inclined to malfunction as a result of kinking.


The application and combination of features and solutions presented by the present invention is not limited to the presented embodiments. One or more features of one embodiment can and may be combined with one or more not disclosed features of other embodiments, whereby not described, but valid, embodiments of the present invention may be obtained. One example is that the cannula according to the present invention may form part of an infusion device provided with means for monitoring or asserting whether or not the cannula of the infusion set is inserted as intended. Such means could inter alia constitute means configured for measuring impedance, where one option of performing the measurement by means of measuring impedance could be by using a drug such as insulin present in the cannula as an electrode.


The term “comprises/comprising/comprised of” when used in this specification incl. claims is taken to specify the presence of stated features, integers, steps or components but does not preclude the presence or addition of one or more other features, integers, steps, components or groups thereof.

Claims
  • 1. An infusion device configured for subcutaneous placement by an insertion needle and infusion of a drug comprising: a cannula having a tubular body member, defining a conduit, with a proximal end and a subcutaneously placed distal portion having a wall and a distal end, wherein said distal portion comprises a soft material, wherein the soft material comprises a material selected from PTFE, FEP, rubber, PE material or silicone base materials, and wherein said distal portion further comprises at least two radial openings along the wall of the distal portion and an outlet at the distal end allowing a portion of the drug conveyed through said tubular body member to discharge into subcutaneous tissue of a patient, wherein the at least two radial openings discharge the drug towards the distal end of the cannula, and wherein the at least two radial openings along the wall of the distal portion have a diameter between 10 μm and 0.5 mm and the outlet at the distal end has an outer diameter of less than 1.5 mm, and wherein two of the at least two radial openings are not located opposite each other including where the two radial openings are offset from each other along a longitudinal axis, and with respect to an angle seen from the outlet;wherein a length of said distal portion of said cannula is less than 15 mm and the length permits a portion of the insertion needle to extend past the outlet of the distal end during placement of the infusion device;a hub part configured to be fastened onto an outside surface of a patient's skin via a mounting pad, wherein the at least two radial openings reduce occlusion due to kinking of the cannula;wherein the outlet of said cannula is tapered to facilitate insertion of the cannula with the insertion needle and the angle between two of the at least two radial openings is substantially 120 degrees.
  • 2. The infusion device according to claim 1, wherein said at least two radial openings are positioned at least 1 millimeter below the skin surface when said cannula is subcutaneously placed.
  • 3. The infusion device according to claim 1, wherein said at least two radial openings are positioned no more than 9 millimeters below the skin surface when said cannula is subcutaneously placed.
  • 4. The infusion device according to claim 1, wherein said at least two radial openings are positioned below the basal membrane when said cannula is subcutaneously placed.
  • 5. The infusion device according to claim 1, wherein said at least two radial openings are positioned no more than 3 millimeters below the skin surface when said cannula is subcutaneously placed.
  • 6. The infusion device according to claim 1, wherein said device further comprises a pump in fluid connection with a reservoir configured to store medication.
  • 7. The infusion device according to claim 1, wherein said infusion device is configured for subcutaneous infusion of one or more drugs.
  • 8. The infusion device according to claim 7, wherein said one or more drugs comprise insulin.
  • 9. The infusion device according to claim 1 wherein the at least two radial openings include a first radial opening inclined with respect to the longitudinal axis and toward the outlet, a second radial opening substantially perpendicular to the longitudinal axis, and a third radial opening inclined with respect to the longitudinal axis and away from the outlet.
  • 10. The infusion device according to claim 1, wherein the infusion device comprises three or more radial openings.
  • 11. The infusion device according to claim 10, wherein said plurality of radial openings extending through said tubular body member have substantially equal diameter.
  • 12. The infusion device according to claim 10, wherein said plurality of radial openings extending through said tubular body member have varying diameters.
  • 13. The infusion device according to claim 12, wherein said plurality of radial openings having varying diameters are configured such that the radial opening having a smallest diameter is arranged nearest said distal portion of said cannula.
  • 14. The infusion device according to claim 12, wherein said plurality of radial openings having varying diameters are configured such that the radial opening having a smallest diameter is arranged nearest said proximal end of said cannula.
Priority Claims (1)
Number Date Country Kind
10186437 Oct 2010 EP regional
Parent Case Info

This application claims the benefit under 35 U.S.C. § 371 of International Application No. PCT/EP2011/067066, filed Sep. 30, 2011, which claims the benefit of U.S. Provisional Application Ser. No. 61/389,595, filed Oct. 4, 2010 and European Application No. 10186437.9, filed Oct. 4, 2010, which are incorporated by reference herein in their entirety.

PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/EP2011/067066 9/30/2011 WO 00 6/10/2013
Publishing Document Publishing Date Country Kind
WO2012/045667 4/12/2012 WO A
US Referenced Citations (586)
Number Name Date Kind
1592462 MacGregor Jul 1926 A
2047010 Dickinson Jul 1936 A
2295849 Kayden Sep 1942 A
2690529 Lindblad Sep 1954 A
2972779 Cowley Feb 1961 A
3059802 Mitchell Oct 1962 A
3074541 Roehr Jan 1963 A
3149186 Coanda Sep 1964 A
3221739 Rosenthal Dec 1965 A
3221740 Rosenthal Dec 1965 A
3306291 Burke Feb 1967 A
3485352 Pilger Dec 1969 A
3509879 Bathish et al. May 1970 A
3519158 Anderson Jul 1970 A
3547119 Hall et al. Dec 1970 A
3575337 Bernhardt Apr 1971 A
3610240 Harautuneian Oct 1971 A
3615039 Ward Oct 1971 A
3670727 Reiterman Jun 1972 A
3783895 Weichselbaum Jan 1974 A
3788374 Saijo Jan 1974 A
3810469 Hurschman May 1974 A
3835862 Villari Sep 1974 A
3840011 Wright Oct 1974 A
3893448 Brantigan Jul 1975 A
3937219 Karakashian Feb 1976 A
3986507 Watt Oct 1976 A
3986508 Barrington Oct 1976 A
3995518 Spiroff Dec 1976 A
4022205 Tenczar May 1977 A
4188950 Wardlaw Feb 1980 A
4201406 Dennehey et al. May 1980 A
4227528 Wardlaw Oct 1980 A
4259276 Rawlings Mar 1981 A
4267836 Whitney et al. May 1981 A
4296786 Brignola Oct 1981 A
4315505 Crandall et al. Feb 1982 A
4333455 Bodicky Jun 1982 A
4334551 Pfister Jun 1982 A
D267199 Koenig Dec 1982 S
4378015 Wardlaw Mar 1983 A
4402407 Maly Sep 1983 A
4415393 Grimes Nov 1983 A
4417886 Frankhouser et al. Nov 1983 A
4464178 Dalton Aug 1984 A
4473369 Lueders et al. Sep 1984 A
4484910 Sarnoff et al. Nov 1984 A
4500312 McFarlane Feb 1985 A
4508367 Oreopoulos et al. Apr 1985 A
4525157 Vaillancourt Jun 1985 A
4530695 Phillips et al. Jul 1985 A
4531937 Yates Jul 1985 A
4543088 Bootman et al. Sep 1985 A
4563177 Kamen Jan 1986 A
4610469 Wolff-Mooij Sep 1986 A
4617019 Fecht Oct 1986 A
4713059 Bickelhaupt et al. Dec 1987 A
4734092 Millerd Mar 1988 A
4755173 Konopka et al. Jul 1988 A
4817603 Turner et al. Apr 1989 A
RE32922 Levin et al. May 1989 E
4838871 Luther Jun 1989 A
4840613 Balbierz Jun 1989 A
4850974 Bickelhaupt et al. Jul 1989 A
4850996 Cree Jul 1989 A
4863016 Fong et al. Sep 1989 A
4878897 Katzin Nov 1989 A
4890608 Steer Jan 1990 A
4894054 Miskinyar Jan 1990 A
4895570 Larkin Jan 1990 A
4917669 Bonaldo Apr 1990 A
4935010 Cox et al. Jun 1990 A
4950163 Zimble Aug 1990 A
4950252 Luther et al. Aug 1990 A
4956989 Nakajima Sep 1990 A
4970954 Weir et al. Nov 1990 A
4978338 Melsky et al. Dec 1990 A
4982842 Hollister Jan 1991 A
4986817 Code Jan 1991 A
4994042 Vadher Feb 1991 A
4994045 Ranford Feb 1991 A
5011475 Olson Apr 1991 A
5020665 Bruno Jun 1991 A
5024662 Menes et al. Jun 1991 A
5067496 Eisele Nov 1991 A
5092853 Couvertier, II Mar 1992 A
5098389 Cappucci Mar 1992 A
5112313 Sallee May 1992 A
5116319 Van den Haak May 1992 A
5116325 Paterson May 1992 A
5121751 Panalletta Jun 1992 A
5129884 Dysarz Jul 1992 A
5135502 Koenig, Jr. et al. Aug 1992 A
5137516 Rand et al. Aug 1992 A
5137524 Lynn et al. Aug 1992 A
5141496 Dalto et al. Aug 1992 A
5147375 Sullivan et al. Sep 1992 A
5163915 Holleron Nov 1992 A
5172808 Bruno Dec 1992 A
5176643 Kramer et al. Jan 1993 A
5176650 Haining Jan 1993 A
5176662 Bartholomew et al. Jan 1993 A
5186712 Kelso et al. Feb 1993 A
5188611 Orgain Feb 1993 A
RE34223 Bonaldo Apr 1993 E
5205820 Kriesel Apr 1993 A
5222947 D'Amico Jun 1993 A
5232454 Hollister Aug 1993 A
5248301 Koenig et al. Sep 1993 A
5256149 Banik et al. Oct 1993 A
5256152 Marks Oct 1993 A
5257980 Van Antwerp et al. Nov 1993 A
5267963 Bachynsky Dec 1993 A
5267979 Appling et al. Dec 1993 A
5269799 Daniel Dec 1993 A
5271744 Kramer et al. Dec 1993 A
5279579 D'Amico Jan 1994 A
5279591 Simon Jan 1994 A
5282793 Larson Feb 1994 A
5300030 Crossman et al. Apr 1994 A
5312359 Wallace May 1994 A
5312369 Arcusin et al. May 1994 A
5316246 Scott et al. May 1994 A
5324302 Crouse Jun 1994 A
5342319 Watson et al. Aug 1994 A
5342324 Tucker Aug 1994 A
5344007 Nakamura et al. Sep 1994 A
5350392 Purcell et al. Sep 1994 A
5354280 Haber et al. Oct 1994 A
5354337 Hoy Oct 1994 A
5366469 Steg et al. Nov 1994 A
5372592 Gambale Dec 1994 A
5372787 Ritter Dec 1994 A
5376082 Phelps Dec 1994 A
5379895 Foslien Jan 1995 A
5380307 Chee et al. Jan 1995 A
5384174 Ward et al. Jan 1995 A
5387197 Smith et al. Feb 1995 A
5390669 Stuart et al. Feb 1995 A
5391151 Wilmot Feb 1995 A
5403288 Stanners Apr 1995 A
5405332 Opalek Apr 1995 A
5425715 Dalling et al. Jun 1995 A
5429607 McPhee Jul 1995 A
5429613 D'Amico Jul 1995 A
5439473 Jorgensen Aug 1995 A
D362718 Deily et al. Sep 1995 S
5449349 Sallee et al. Sep 1995 A
5451210 Kramer et al. Sep 1995 A
5478316 Bitdinger et al. Dec 1995 A
5490841 Landis Feb 1996 A
5501675 Erskine Mar 1996 A
5505709 Funderburk et al. Apr 1996 A
5507730 Haber et al. Apr 1996 A
5514117 Lynn May 1996 A
5520654 Wahlberg May 1996 A
5522803 Teissen-Simony Jun 1996 A
5527287 Miskinyar et al. Jun 1996 A
5533974 Gaba Jul 1996 A
5540709 Ramel Jul 1996 A
5545143 Fischell Aug 1996 A
5545152 Funderburk et al. Aug 1996 A
5549577 Siegel et al. Aug 1996 A
5554130 McDonald et al. Sep 1996 A
5558650 McPhee Sep 1996 A
5562629 Haughton et al. Oct 1996 A
5562636 Utterberg Oct 1996 A
5573510 Isaacson Nov 1996 A
5575777 Cover et al. Nov 1996 A
5584813 Livingston et al. Dec 1996 A
5586553 Halili et al. Dec 1996 A
5591188 Waisman Jan 1997 A
5599309 Marshall et al. Feb 1997 A
5599315 McPhee Feb 1997 A
5599318 Sweeney et al. Feb 1997 A
5628765 Morita May 1997 A
5643214 Marshall Jul 1997 A
5643216 White Jul 1997 A
5643220 Cosme Jul 1997 A
5658256 Shields Aug 1997 A
5662617 Odell et al. Sep 1997 A
5665071 Wyrick Sep 1997 A
5665075 Gyure et al. Sep 1997 A
5676156 Yoon Oct 1997 A
5681323 Arick Oct 1997 A
5695476 Harris Dec 1997 A
5697907 Gaba Dec 1997 A
5700250 Erskine Dec 1997 A
5702371 Bierman Dec 1997 A
5704920 Gyure Jan 1998 A
5709662 Olive et al. Jan 1998 A
5714225 Hansen et al. Feb 1998 A
5738641 Watson et al. Apr 1998 A
5741288 Rife Apr 1998 A
5752923 Terwilliger May 1998 A
5807316 Teeple Sep 1998 A
5807348 Zinger et al. Sep 1998 A
5810835 Ryan et al. Sep 1998 A
5817058 Shaw Oct 1998 A
5820598 Gazza et al. Oct 1998 A
5827236 Takahashi Oct 1998 A
5833666 Davis et al. Nov 1998 A
5843001 Goldenberg Dec 1998 A
5848990 Cirelli et al. Dec 1998 A
5851197 Marano et al. Dec 1998 A
5858001 Tsals et al. Jan 1999 A
5865806 Howell Feb 1999 A
5899886 Cosme May 1999 A
5911705 Howell Jun 1999 A
5913846 Szabo Jun 1999 A
5916199 Miles Jun 1999 A
5919167 Mulhauser et al. Jul 1999 A
5919170 Woessner Jul 1999 A
5925032 Clements Jul 1999 A
5935109 Donnan Aug 1999 A
5947931 Bierman Sep 1999 A
5947935 Rhinehart et al. Sep 1999 A
5951523 Osterlind et al. Sep 1999 A
5954643 VanAntwerp et al. Sep 1999 A
5957892 Thorne Sep 1999 A
5957897 Jeffrey Sep 1999 A
5968011 Larsen et al. Oct 1999 A
5971966 Lav Oct 1999 A
5975120 Novosel Nov 1999 A
5980488 Thorne Nov 1999 A
5980506 Mathiasen Nov 1999 A
5984224 Yang Nov 1999 A
5984897 Petersen et al. Nov 1999 A
D417733 Howell et al. Dec 1999 S
6017328 Fischell et al. Jan 2000 A
6017598 Kreischer et al. Jan 2000 A
D421119 Musgrave et al. Feb 2000 S
6024727 Thorne et al. Feb 2000 A
6039629 Mitchell Mar 2000 A
6042570 Bell et al. Mar 2000 A
6045533 Kriesel et al. Apr 2000 A
6045534 Jacobsen et al. Apr 2000 A
6050976 Thorne et al. Apr 2000 A
6053893 Bucher Apr 2000 A
6053930 Ruppert Apr 2000 A
6056718 Funderburk et al. May 2000 A
6056726 Isaacson May 2000 A
6074369 Sage et al. Jun 2000 A
6074371 Fischell Jun 2000 A
6077244 Botich et al. Jun 2000 A
6079432 Paradis Jun 2000 A
6086008 Gray et al. Jul 2000 A
6086575 Mejslov Jul 2000 A
6090068 Chanut Jul 2000 A
6093172 Funderburk et al. Jul 2000 A
6093179 O'Hara et al. Jul 2000 A
6099503 Stradella Aug 2000 A
6105218 Reekie Aug 2000 A
6106498 Friedli et al. Aug 2000 A
6120482 Szabo Sep 2000 A
6123690 Mejslov Sep 2000 A
6132755 Eicher et al. Oct 2000 A
6139534 Niedospial, Jr. Oct 2000 A
6159181 Crossman et al. Dec 2000 A
6183464 Sharp et al. Feb 2001 B1
6191338 Haller Feb 2001 B1
6193694 Bell et al. Feb 2001 B1
6210420 Mauze et al. Apr 2001 B1
6219574 Cormier et al. Apr 2001 B1
6221058 Kao et al. Apr 2001 B1
6248093 Moberg Jun 2001 B1
6261272 Gross et al. Jul 2001 B1
6280434 Kinoshita Aug 2001 B1
6293925 Safabash et al. Sep 2001 B1
6302866 Marggi Oct 2001 B1
6319232 Kashmer Nov 2001 B1
6322535 Hitchins et al. Nov 2001 B1
6322808 Trautman et al. Nov 2001 B1
6334856 Allen et al. Jan 2002 B1
6355021 Nielsen et al. Mar 2002 B1
6364113 Faasse et al. Apr 2002 B1
6378218 Sigwart et al. Apr 2002 B2
6379335 Rigon et al. Apr 2002 B1
6387076 Van Landuyt May 2002 B1
6387078 Gillespie, III May 2002 B1
6405876 Seshimoto et al. Jun 2002 B1
6440096 Lastovich et al. Aug 2002 B1
6447482 Rønborg et al. Sep 2002 B1
6450992 Cassidy, Jr. Sep 2002 B1
6485461 Mason et al. Nov 2002 B1
6488663 Steg Dec 2002 B1
6503222 Lo Jan 2003 B2
6517517 Farrugia et al. Feb 2003 B1
6517521 Ly Feb 2003 B1
6520938 Funderburk et al. Feb 2003 B1
D472316 Douglas et al. Mar 2003 S
6533763 Schneiter Mar 2003 B1
D472630 Douglas et al. Apr 2003 S
6572586 Wojcik Jun 2003 B1
6579267 Lynch et al. Jun 2003 B2
6582397 Alesi et al. Jun 2003 B2
6595962 Perthu Jul 2003 B1
6607509 Bobroff et al. Aug 2003 B2
6607511 Halseth et al. Aug 2003 B2
6613064 Rutynowski et al. Sep 2003 B2
6620133 Steck Sep 2003 B1
6620136 Pressly, Sr. et al. Sep 2003 B1
6620140 Metzger Sep 2003 B1
6629949 Douglas Oct 2003 B1
6645181 Lavi et al. Nov 2003 B1
6645182 Szabo Nov 2003 B1
6659982 Douglas et al. Dec 2003 B2
6685674 Douglas et al. Feb 2004 B2
6689118 Alohas et al. Feb 2004 B2
6699218 Flaherty et al. Mar 2004 B2
6702779 Connelly et al. Mar 2004 B2
6726649 Swenson et al. Apr 2004 B2
6736797 Larsen et al. May 2004 B1
6743203 Pickhard Jun 2004 B1
6749587 Flaherty Jun 2004 B2
6749589 Douglas et al. Jun 2004 B1
6755805 Reid Jun 2004 B1
6776775 Mohammad Aug 2004 B1
6790199 Gianakos Sep 2004 B1
6805686 Fathallah et al. Oct 2004 B1
6808506 Lastovich et al. Oct 2004 B2
6811545 Vaillancourt Nov 2004 B2
6814720 Olsen et al. Nov 2004 B2
6824530 Wagner et al. Nov 2004 B2
6824531 Zecha, Jr. et al. Nov 2004 B1
6830562 Mogensen et al. Dec 2004 B2
6837877 Zurcher Jan 2005 B2
6837878 Smutney et al. Jan 2005 B2
6840922 Nielsen et al. Jan 2005 B2
6880701 Bergeron et al. Apr 2005 B2
6923791 Douglas Aug 2005 B2
6926694 Marano-Ford et al. Aug 2005 B2
6939324 Gonnelli et al. Sep 2005 B2
6939331 Ohshima Sep 2005 B2
6949084 Marggi et al. Sep 2005 B2
6959812 Reif et al. Nov 2005 B2
6960193 Rosenberg Nov 2005 B2
6979316 Rubin et al. Dec 2005 B1
6991619 Marano-Ford et al. Jan 2006 B2
6991620 Marano-Ford et al. Jan 2006 B2
6994213 Giard et al. Feb 2006 B2
6997907 Safabash et al. Feb 2006 B2
7014625 Bengtsson Mar 2006 B2
7018344 Bressler et al. Mar 2006 B2
7022108 Marano-Ford et al. Apr 2006 B2
7047070 Wilkinson et al. May 2006 B2
7052483 Wojcik May 2006 B2
7055713 Rea et al. Jun 2006 B2
7056302 Douglas Jun 2006 B2
7070580 Nielsen Jul 2006 B2
7074208 Pajunk et al. Jul 2006 B2
D526409 Nielsen et al. Aug 2006 S
7083592 Lastovich et al. Aug 2006 B2
7083597 Lynch et al. Aug 2006 B2
7097631 Trautman et al. Aug 2006 B2
7109878 Mann et al. Sep 2006 B2
7115108 Wilkinson et al. Oct 2006 B2
7115112 Mogensen et al. Oct 2006 B2
7137968 Burrell et al. Nov 2006 B1
7141023 Diermann et al. Nov 2006 B2
7147623 Mathiasen Dec 2006 B2
7186236 Gibson et al. Mar 2007 B2
7211068 Douglas May 2007 B2
7214207 Lynch et al. May 2007 B2
7214215 Heinzerling et al. May 2007 B2
7250037 Shermer et al. Jul 2007 B2
7258680 Mogensen et al. Aug 2007 B2
D554253 Kornerup Oct 2007 S
7303543 Maule et al. Dec 2007 B1
7309326 Fangrow, Jr. Dec 2007 B2
7322473 Fux Jan 2008 B2
7407491 Fangrow, Jr. Aug 2008 B2
7407493 Cane′ Aug 2008 B2
7431876 Mejlhede et al. Oct 2008 B2
7441655 Hoftman Oct 2008 B1
7569262 Szabo et al. Aug 2009 B2
7648494 Kornerup et al. Jan 2010 B2
7766867 Lynch et al. Aug 2010 B2
7846132 Gravesen et al. Dec 2010 B2
7850652 Liniger et al. Dec 2010 B2
8012126 Tipsmark et al. Sep 2011 B2
8087333 Oishi Jan 2012 B2
8123724 Gillespie, III Feb 2012 B2
8303549 Mejlhede et al. Nov 2012 B2
8323250 Chong et al. Dec 2012 B2
20010004970 Hollister et al. Jun 2001 A1
20010016714 Bell et al. Aug 2001 A1
20010021827 Ferguson et al. Sep 2001 A1
20010039387 Rutynowski et al. Nov 2001 A1
20010039401 Ferguson et al. Nov 2001 A1
20010041875 Higuchi et al. Nov 2001 A1
20010049496 Kirchhofer Dec 2001 A1
20010053889 Marggi Dec 2001 A1
20010056284 Purcell et al. Dec 2001 A1
20020022798 Connelly et al. Feb 2002 A1
20020022855 Bobroff et al. Feb 2002 A1
20020026152 Bierman Feb 2002 A1
20020055711 Lavi et al. May 2002 A1
20020068904 Bierman et al. Jun 2002 A1
20020072720 Hague et al. Jun 2002 A1
20020074345 Schneider et al. Jun 2002 A1
20020077599 Wojcik Jun 2002 A1
20020082543 Park et al. Jun 2002 A1
20020095138 Lynch et al. Jul 2002 A1
20020107489 Lee Aug 2002 A1
20020111581 Sasso Aug 2002 A1
20020156424 Suzuki et al. Oct 2002 A1
20020156427 Suzuki et al. Oct 2002 A1
20020161322 Utterberg et al. Oct 2002 A1
20020161332 Ramey Oct 2002 A1
20020161386 Halseth et al. Oct 2002 A1
20020165493 Bierman Nov 2002 A1
20020169419 Steg Nov 2002 A1
20020173748 McConnell et al. Nov 2002 A1
20020173769 Gray et al. Nov 2002 A1
20020183688 Lastovich et al. Dec 2002 A1
20020189688 Roorda Dec 2002 A1
20020193737 Popovsky Dec 2002 A1
20020193744 Alesi et al. Dec 2002 A1
20030014018 Giambattista et al. Jan 2003 A1
20030060781 Mogensen et al. Mar 2003 A1
20030069548 Connelly et al. Apr 2003 A1
20030088238 Poulsen et al. May 2003 A1
20030105430 Lavi et al. Jun 2003 A1
20030109829 Mogensen et al. Jun 2003 A1
20030125669 Safabash et al. Jul 2003 A1
20030125678 Swenson et al. Jul 2003 A1
20030130619 Safabash et al. Jul 2003 A1
20030139704 Lin Jul 2003 A1
20030158520 Safabash et al. Aug 2003 A1
20030176843 Wilkinson Sep 2003 A1
20030176852 Lynch et al. Sep 2003 A1
20030181863 Ackley et al. Sep 2003 A1
20030181868 Swenson Sep 2003 A1
20030181873 Swenson Sep 2003 A1
20030181874 Bressler et al. Sep 2003 A1
20030187394 Wilkinson et al. Oct 2003 A1
20030187395 Gabel Oct 2003 A1
20030199823 Bobroff et al. Oct 2003 A1
20030216686 Lynch et al. Nov 2003 A1
20030220610 Lastovich et al. Nov 2003 A1
20030225373 Bobroff et al. Dec 2003 A1
20030225374 Mathiasen Dec 2003 A1
20030229308 Tsals et al. Dec 2003 A1
20030229316 Hwang et al. Dec 2003 A1
20040002682 Kovelman et al. Jan 2004 A1
20040006316 Patton Jan 2004 A1
20040030220 Hamm Feb 2004 A1
20040044306 Lynch et al. Mar 2004 A1
20040049159 Barrus et al. Mar 2004 A1
20040055711 Martin et al. Mar 2004 A1
20040059316 Smedegaard Mar 2004 A1
20040068231 Blondeau Apr 2004 A1
20040069044 Lavi et al. Apr 2004 A1
20040087913 Rogers et al. May 2004 A1
20040092865 Flaherty et al. May 2004 A1
20040092875 Kochamba May 2004 A1
20040111068 Swenson Jun 2004 A1
20040112781 Hofverberg et al. Jun 2004 A1
20040116865 Bengtsson Jun 2004 A1
20040133164 Funderburk et al. Jul 2004 A1
20040138612 Shermer et al. Jul 2004 A1
20040138620 Douglas et al. Jul 2004 A1
20040143216 Douglas et al. Jul 2004 A1
20040143218 Das Jul 2004 A1
20040158202 Jensen Aug 2004 A1
20040158207 Hunn et al. Aug 2004 A1
20040162518 Connelly et al. Aug 2004 A1
20040162521 Bengtsson Aug 2004 A1
20040171989 Horner et al. Sep 2004 A1
20040178098 Swenson et al. Sep 2004 A1
20040186446 Ohshima Sep 2004 A1
20040193143 Sauer Sep 2004 A1
20040199123 Nielsen Oct 2004 A1
20040204673 Flaherty et al. Oct 2004 A1
20040204687 Mogensen et al. Oct 2004 A1
20040204690 Yashiro et al. Oct 2004 A1
20040215151 Marshall et al. Oct 2004 A1
20040220528 Garcia, Jr. Nov 2004 A1
20040236284 Hoste et al. Nov 2004 A1
20040238392 Peterson et al. Dec 2004 A1
20040243065 McConnell et al. Dec 2004 A1
20040254433 Bandis et al. Dec 2004 A1
20040260235 Douglas Dec 2004 A1
20040260250 Harris et al. Dec 2004 A1
20050035014 Cane Feb 2005 A1
20050038378 Lastovich et al. Feb 2005 A1
20050043687 Mogensen et al. Feb 2005 A1
20050049571 Lastovich et al. Mar 2005 A1
20050065466 Vedrine Mar 2005 A1
20050065472 Cindrich et al. Mar 2005 A1
20050075606 Botich et al. Apr 2005 A1
20050080386 Reid Apr 2005 A1
20050101910 Bowman et al. May 2005 A1
20050101912 Faust et al. May 2005 A1
20050101932 Cote et al. May 2005 A1
20050101933 Marrs et al. May 2005 A1
20050107743 Fangrow, Jr. May 2005 A1
20050113761 Faust et al. May 2005 A1
20050119611 Marano-Ford et al. Jun 2005 A1
20050119619 Haining Jun 2005 A1
20050119637 Lundgren et al. Jun 2005 A1
20050124936 Mogensen et al. Jun 2005 A1
20050131347 Marano-Ford et al. Jun 2005 A1
20050159709 Wilkinson Jul 2005 A1
20050159714 Gibson Jul 2005 A1
20050165382 Fulford Jul 2005 A1
20050192560 Walls et al. Sep 2005 A1
20050203461 Flaherty et al. Sep 2005 A1
20050215979 Kornerup et al. Sep 2005 A1
20050240154 Mogensen et al. Oct 2005 A1
20050251098 Wyss et al. Nov 2005 A1
20050256456 Marano-Ford et al. Nov 2005 A1
20050261629 Marano-Ford et al. Nov 2005 A1
20050277892 Chen Dec 2005 A1
20050283114 Bresina et al. Dec 2005 A1
20060015063 Butikofer et al. Jan 2006 A1
20060015076 Heinzerling et al. Jan 2006 A1
20060030815 Csincsura et al. Feb 2006 A1
20060036214 Mogensen et al. Feb 2006 A1
20060041224 Jensen Feb 2006 A1
20060069351 Safabash et al. Mar 2006 A9
20060069382 Pedersen Mar 2006 A1
20060069383 Bogaerts et al. Mar 2006 A1
20060095003 Marano-Ford et al. May 2006 A1
20060095014 Ethelfeld May 2006 A1
20060106346 Sullivan et al. May 2006 A1
20060129123 Wojcik Jun 2006 A1
20060135908 Liniger et al. Jun 2006 A1
20060135913 Ethelfeld Jun 2006 A1
20060142698 Ethelfeld Jun 2006 A1
20060161108 Mogensen et al. Jul 2006 A1
20060173410 Moberg et al. Aug 2006 A1
20060173413 Fan Aug 2006 A1
20060184104 Cheney, II et al. Aug 2006 A1
20060184140 Okiyama Aug 2006 A1
20060200073 Radmer et al. Sep 2006 A1
20060241551 Lynch et al. Oct 2006 A1
20060247553 Diermann et al. Nov 2006 A1
20060247574 Maule et al. Nov 2006 A1
20060253085 Geismar et al. Nov 2006 A1
20060253086 Moberg et al. Nov 2006 A1
20060264835 Nielsen et al. Nov 2006 A1
20060264890 Moberg et al. Nov 2006 A1
20070005017 Alchas et al. Jan 2007 A1
20070016129 Liniger et al. Jan 2007 A1
20070016159 Sparholt et al. Jan 2007 A1
20070021729 Mogensen et al. Jan 2007 A1
20070049865 Radmer et al. Mar 2007 A1
20070049870 Gray et al. Mar 2007 A1
20070051784 Money et al. Mar 2007 A1
20070066955 Sparholt et al. Mar 2007 A1
20070066958 Wright Mar 2007 A1
20070088271 Richards et al. Apr 2007 A1
20070093754 Mogensen et al. Apr 2007 A1
20070104596 Preuthun et al. May 2007 A1
20070112301 Preuthun et al. May 2007 A1
20070112303 Liniger May 2007 A1
20070129688 Scheurer et al. Jun 2007 A1
20070129691 Sage, Jr. et al. Jun 2007 A1
20070173767 Lynch et al. Jul 2007 A1
20070191772 Wojcik Aug 2007 A1
20070191773 Wojcik Aug 2007 A1
20070203454 Shermer et al. Aug 2007 A1
20070185441 Fangrow, Jr. Sep 2007 A1
20070213673 Douglas Sep 2007 A1
20070179444 Causey et al. Oct 2007 A1
20070244448 Lastovich et al. Oct 2007 A1
20070282269 Carter et al. Dec 2007 A1
20070299409 Whitbourne et al. Dec 2007 A1
20080021375 Burns Jan 2008 A1
20080058692 Propp et al. Mar 2008 A1
20080119707 Stafford May 2008 A1
20080200897 Hoss et al. Aug 2008 A1
20080269687 Chong Oct 2008 A1
20080312601 Cane′ Dec 2008 A1
20090062767 Van Antwerp et al. Mar 2009 A1
20090118592 Klitgaard May 2009 A1
20090326456 Cross et al. Dec 2009 A1
20100004597 Gyrn et al. Jan 2010 A1
20100022956 Tipsmark et al. Jan 2010 A1
20100137829 Nielsen et al. Jun 2010 A1
20100228226 Nielsen Sep 2010 A1
20100262078 Blomquist Oct 2010 A1
20110054399 Chong et al. Mar 2011 A1
20130024555 Bartfai-Walcott et al. Jan 2013 A1
Foreign Referenced Citations (209)
Number Date Country
4 342 329 Jun 1994 DE
196 31 921 Mar 1997 DE
299 05 072 Sep 1999 DE
101 17 285 Nov 2002 DE
203 20 207 Nov 2004 DE
0117632 Sep 1984 EP
0239244 Feb 1987 EP
0272530 Jun 1988 EP
0451040 Oct 1991 EP
0544837 Jun 1993 EP
0615768 Sep 1994 EP
0651662 May 1995 EP
0652027 May 1995 EP
0657184 Jun 1995 EP
0688232 Dec 1995 EP
0714631 Jun 1996 EP
0744183 Nov 1996 EP
0747006 Dec 1996 EP
0775501 May 1997 EP
0799626 Oct 1997 EP
0937475 Aug 1999 EP
0956879 Nov 1999 EP
1086718 Mar 2001 EP
1125593 Aug 2001 EP
1329233 Jul 2003 EP
1350537 Oct 2003 EP
1360970 Nov 2003 EP
1380315 Jan 2004 EP
1407747 Apr 2004 EP
1407793 Apr 2004 EP
1421968 May 2004 EP
1177802 Sep 2004 EP
1475113 Nov 2004 EP
1495775 Jan 2005 EP
1502613 Feb 2005 EP
1525873 Apr 2005 EP
1527792 May 2005 EP
1559442 Aug 2005 EP
1616594 Jan 2006 EP
1704889 Sep 2006 EP
1719537 Nov 2006 EP
1762259 Mar 2007 EP
1764125 Mar 2007 EP
1776980 Apr 2007 EP
1970091 Sep 2008 EP
2272559 Jan 2011 EP
2725902 Oct 1994 FR
2 752 164 Feb 1998 FR
906574 Sep 1962 GB
2 088 215 Jun 1982 GB
2 230 702 Oct 1990 GB
2 423 267 Aug 2006 GB
2 450 872 Jul 2007 GB
2 459 101 Oct 2009 GB
2459101 Oct 2009 GB
10179734 Aug 1991 JP
7051251 Nov 1995 JP
8187286 Jul 1996 JP
03-191965 Jul 1998 JP
2002-028246 Jan 2002 JP
2 238 111 Dec 2003 RU
933 100 Jun 1982 SU
WO 8101795 Jul 1981 WO
WO 8203558 Oct 1982 WO
WO 9204062 Mar 1992 WO
WO 9305840 Apr 1993 WO
WO 9311709 Jun 1993 WO
WO 9420160 Sep 1994 WO
WO 9519194 Jul 1995 WO
WO 9620021 Jul 1996 WO
WO 9632981 Oct 1996 WO
WO 9826835 Jun 1998 WO
WO 9833549 Aug 1998 WO
WO 9858693 Dec 1998 WO
WO 9907435 Feb 1999 WO
WO 9922789 May 1999 WO
WO 9933504 Jul 1999 WO
WO 0002614 Jan 2000 WO
WO 0003757 Jan 2000 WO
WO 0044324 Aug 2000 WO
WO 0112746 Feb 2001 WO
WO 0130419 May 2001 WO
WO 0168180 Sep 2001 WO
WO 0172353 Oct 2001 WO
WO 0176684 Oct 2001 WO
WO 0193926 Dec 2001 WO
WO 0202165 Jan 2002 WO
WO 0207804 Jan 2002 WO
WO 02040083 May 2002 WO
WO 02053220 Jul 2002 WO
WO 02068014 Sep 2002 WO
WO 02081012 Oct 2002 WO
WO 02081013 Oct 2002 WO
WO 02083206 Oct 2002 WO
WO 02083228 Oct 2002 WO
WO-02083228 Oct 2002 WO
WO 02094352 Nov 2002 WO
WO 02100457 Dec 2002 WO
WO 02102442 Dec 2002 WO
WO 03015860 Feb 2003 WO
WO 03026728 Apr 2003 WO
WO 03068305 Aug 2003 WO
WO 03075980 Sep 2003 WO
WO 03095003 Nov 2003 WO
WO 2004012796 Feb 2004 WO
WO 2004024219 Mar 2004 WO
WO-2004024219 Mar 2004 WO
WO 2004026375 Apr 2004 WO
WO 2004029457 Apr 2004 WO
WO 2004030726 Apr 2004 WO
WO 2004056412 Apr 2004 WO
WO 2004037325 May 2004 WO
WO 2004054644 Jul 2004 WO
WO 2004064593 Aug 2004 WO
WO 2004071308 Aug 2004 WO
WO 2004087240 Oct 2004 WO
WO 2004098683 Nov 2004 WO
WO 2004101016 Nov 2004 WO
WO 2004101071 Nov 2004 WO
WO 2004110527 Dec 2004 WO
WO 2005002649 Jan 2005 WO
WO 2005004973 Jan 2005 WO
WO 2005018703 Mar 2005 WO
WO 2005037184 Apr 2005 WO
WO 2005037350 Apr 2005 WO
WO 2005039673 May 2005 WO
WO 2005046780 May 2005 WO
WO 2005065748 Jul 2005 WO
WO 2005068006 Jul 2005 WO
WO 2005072795 Aug 2005 WO
WO 2005092410 Oct 2005 WO
WO 2005094920 Oct 2005 WO
WO 2005112800 Dec 2005 WO
WO 2005118055 Dec 2005 WO
WO 2006003130 Jan 2006 WO
WO 2006015507 Feb 2006 WO
WO 2006015600 Feb 2006 WO
WO 2006024650 Mar 2006 WO
WO 2006032689 Mar 2006 WO
WO 2006032692 Mar 2006 WO
WO 2006061027 Jun 2006 WO
WO 2006061354 Jun 2006 WO
WO 2006062680 Jun 2006 WO
WO 2006062912 Jun 2006 WO
WO 2006075016 Jul 2006 WO
WO 2006077262 Jul 2006 WO
WO 2006077263 Jul 2006 WO
WO 2006089958 Aug 2006 WO
WO 2006097111 Sep 2006 WO
WO 2006108775 Oct 2006 WO
WO 2006120253 Nov 2006 WO
WO 2006121921 Nov 2006 WO
WO 2006122048 Nov 2006 WO
WO 2007000162 Jan 2007 WO
WO 2007002523 Jan 2007 WO
WO 2007020090 Feb 2007 WO
WO 2007065944 Jun 2007 WO
WO 2007071255 Jun 2007 WO
WO 2007071258 Jun 2007 WO
WO 2007093051 Aug 2007 WO
WO 2007093182 Aug 2007 WO
WO 2007122207 Nov 2007 WO
WO 2007140631 Dec 2007 WO
WO 2007140783 Dec 2007 WO
WO 2007140785 Dec 2007 WO
WO 2007141210 Dec 2007 WO
WO 2008014791 Feb 2008 WO
WO 2008014792 Feb 2008 WO
WO 2008133702 Mar 2008 WO
WO 2008048631 Apr 2008 WO
WO 2008052545 May 2008 WO
WO 2008065646 Jun 2008 WO
WO 2008092782 Aug 2008 WO
WO 2008092958 Aug 2008 WO
WO 2008092959 Aug 2008 WO
WO 2008135098 Nov 2008 WO
WO 2008147600 Dec 2008 WO
WO 2008148714 Dec 2008 WO
WO 2008155145 Dec 2008 WO
WO 2008155377 Dec 2008 WO
WO 2009004026 Jan 2009 WO
WO 2009007287 Jan 2009 WO
WO 2009010396 Jan 2009 WO
WO 2009010399 Jan 2009 WO
WO 2009016635 Feb 2009 WO
WO 2009033032 Mar 2009 WO
WO 2009039013 Mar 2009 WO
WO 2009098291 Aug 2009 WO
WO 2009098306 Aug 2009 WO
WO 2009101130 Aug 2009 WO
WO 2009101145 Aug 2009 WO
WO 2009103759 Aug 2009 WO
WO 2009106517 Sep 2009 WO
WO 2009144272 Dec 2009 WO
WO 2010003885 Jan 2010 WO
WO 2010003886 Jan 2010 WO
WO 2010030602 Mar 2010 WO
WO 2010034830 Apr 2010 WO
WO 2010072664 Jul 2010 WO
WO 2010080715 Jul 2010 WO
WO-2010080715 Jul 2010 WO
WO 2010112521 Oct 2010 WO
WO 2011012465 Feb 2011 WO
WO 2011015659 Feb 2011 WO
WO 2011121023 Oct 2011 WO
WO 2012041784 Apr 2012 WO
WO 2012041923 Apr 2012 WO
WO 2012045667 Apr 2012 WO
WO 2012107440 Aug 2012 WO
Non-Patent Literature Citations (3)
Entry
International Search Report completed Jun. 27, 2012 for International Application No. PCT/EP2011/067066.
“Why inset®?” inset® infusion set product overview; downloaded from the internet at http://web.archive.org/web/20040906102448/http://www.infusion-set.com/Default.asp?ID=108 on Jan. 1, 2008; two pages.
International Application No. PCT/EP2011/067066 International Search Report and Written Opinion dated Jul. 6, 2012.
Related Publications (1)
Number Date Country
20130245555 A1 Sep 2013 US
Provisional Applications (1)
Number Date Country
61389595 Oct 2010 US